Description: A multiway typology of measures of aging, longevity and superlongevity is presented, with measures classified as measures of aging and longevity, direct and indirect measures of aging and longevity, and measures based on population data, death statistics and life table functions.

Description: Small companies face numerous challenges and opportunities when developing supplemental health insurance products. This is particularly true because of the competitive nature of these products and the innovations happening in the supplemental health market. This article explores the challenges regarding rating, the volatile regulatory environment, product flexibility, and distribution. In addition, the article identifies competitive advantages that small companies may have in the supplemental health market.

Description: Panelists discuss potential effects on the health insurance system and implications of future developments in genetic technology. From the Record of the Society of Actuaries, Volume 28, No. 3, Session 53.

Description: Insurance commissioners and deputy insurance commissioners will discuss current topics including health care reform, life insurance issues, risks in the major medical markets, voluntary products and other topics.

Description: Investigate the importance of collaboration with accounting, underwriting, sales, marketing and other professions as an actuary when you attend this webcast. Cross-functional positions can cause unique challenges to arise, like various experts attempting to balance growth and profitability. Discover an opportunity to learn about relevant ASOPs and dive deeper into contemporary examples that highlight specific professionalism issues that can develop.

Description: Develop a better understanding of specialty drug trends and their increasing healthcare costs for more than the past decade by attending this webcast. With the introduction of price competition, you will see changes in the market for biosimilar products and patent-protected drugs. For example, the drug Humira will be gaining 10 biosimilar competitors in 2023. Alone, Humira can represent over 20% of total pharmacy spend for health plans. Join us and discover how price competition is a turning point for the pharmaceutical industry and will define its direction for the next decade.

Description: The editor of Health Watch previews the articles in this issue.

Description: Discover the benefits of building a shared business model during the Building Digital Platforms: Insurtechs, Carriers and Reinsurers webcast. This is an educational event for the actuary interested in product and channel innovation, in addition to those wanting to understand how to juggle competitive incentives in the market. Representatives from Insurtechs, insurance carriers and reinsurers will discuss their distribution development and product capabilities for marketing insurance products on digital platforms, as well as their collaboration throughout the process.

Description: Savings from biosimilars have accelerated significantly in the past few years. There has been a number of relatively recent biosimilar launches that can help to shape our expectations of the financial impact that could result from this year’s big event. Savings from biosimilars have accelerated significantly in the past few years. There has been a number of relatively recent biosimilar launches that can help to shape our expectations of the financial impact that could result from this year’s big event.

Description: A Request for Proposals (RFP) for research studies on the impact of climate change and catastrophes on the U.S. health infrastructure. It outlines the background, objectives, submission requirements, and selection process for potential researchers.